17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Blimp-1 Contributes to the Development and Function of Regulatory B Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Regulatory B cells (Bregs) are a B cell subset that plays a suppressive role in immune responses. The CD19 +CD1d hiCD5 + Bregs that can execute regulatory functions via secreting IL-10 are defined as B10 cells. Bregs suppress autoimmune and inflammatory diseases, whereas they exacerbate infectious diseases caused by bacteria, viruses, or parasites. Notably, the molecular mechanisms regulating the development and functions of Bregs are still largely unknown. Furthermore, the biological impact of Bregs in fungal infection has not yet been demonstrated. Here, we compared the gene expression profiles of IL-10-producing and –non-producing mouse splenic B cells stimulated with lipopolysaccharide (LPS) or anti-CD40 antibody. Blimp-1, a transcription factor known to be critical for plasma cell differentiation, was found to be enriched in the IL-10-producing B cells. The frequency of Blimp-1 + B10 cells was increased in LPS-treated mice and in isolated B10 cells that were stimulated with LPS. Surprisingly, B cell-specific Blimp-1 knockout (Cko) mice, generated by CD19 promoter driven Cre recombinase-dependent deletion of Prdm1 (gene encoding Blimp-1), showed higher frequencies of B10 cells both in the steady state and following injection with LPS, as compared with control littermates. However, B10 cells lacking Blimp-1 failed to efficiently suppress the proliferation of naïve CD4 + T cells primed with anti-CD3 and anti-CD28 antibodies. B10 cells can be stimulated for further differentiation into plasmablasts, and a subset of plasmablasts express IL-10. We found that B10 cells from Cko mice failed to generate both IL-10-non-producing and IL-10-producing plasmablasts. Mechanistically, we found that Blimp-1 can directly suppress Il-10, whereas, in the presence of activated STAT3, Blimp-1 works together with activated STAT3 to upregulate Il-10. Moreover, we also found that B10 cells improve the clearance of Candida albicans infection but worsen the infection mortality. Notably, a lack of Blimp-1 in B10 cells did not change these effects of adoptively transferred B10 cells on fungal infections. Together, our data show that Blimp-1 regulates the generation, differentiation, and IL-10 production of Bregs.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.

          Blimp-1 is a transcriptional repressor able to drive the terminal differentiation of B cells into Ig-secreting plasma cells. We have created mice with a B cell-specific deletion of prdm1, the gene encoding Blimp-1. B cell development and the number of B cells responding to antigen appear to be normal in these mice. However, in response to either TD or TI antigen, serum Ig, short-lived plasma cells, post-GC plasma cells, and plasma cells in a memory response are virtually absent, demonstrating that Blimp-1 is required for plasmacytic differentiation and Ig secretion. In the absence of Blimp-1, CD79b(+)B220(-) pre-plasma memory B cell development is also defective, providing evidence that this subset is an intermediate in plasma cell development. B cells lacking Blimp-1 cannot secrete Ig or induce muS mRNA when stimulated ex vivo. Furthermore, although prdm1-/- B cells fail to induce XBP-1, XBP-1 cannot rescue plasmacytic differentiation without Blimp-1.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation.

            Molecular mechanisms underlying the coordination of isotype switching with plasma cell differentiation are poorly understood. We show that interferon regulatory factor-4 (IRF-4) regulates both processes by controlling the expression of the Aicda and Prdm1 genes, which encode AID and Blimp-1, respectively. Genome-wide analysis demonstrated that Irf4(-/-) B cells failed to induce the entire Blimp-1-dependent plasma cell program. Restoration of AID or Blimp-1 expression in Irf4(-/-) B cells promoted isotype switching or secretion, respectively. IRF-4 was expressed in a graded manner in differentiating B cells and targeted Prdm1. Higher concentration of IRF-4 induced Prdm1 and consequently the transition from a germinal center gene expression program to that of a plasma cell. We propose a gene-regulatory network in which graded expression of IRF-4 developmentally coordinates isotype switching with plasma cell differentiation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

              BCL-6, a transcriptional repressor frequently translocated in lymphomas, regulates germinal center B cell differentiation and inflammation. DNA microarray screening identified genes repressed by BCL-6, including many lymphocyte activation genes, suggesting that BCL-6 modulates B cell receptor signals. BCL-6 repression of two chemokine genes, MIP-1alpha and IP-10, may also attenuate inflammatory responses. Blimp-1, another BCL-6 target, is important for plasmacytic differentiation. Since BCL-6 expression is silenced in plasma cells, repression of blimp-1 by BCL-6 may control plasmacytic differentiation. Indeed, inhibition of BCL-6 function initiated changes indicative of plasmacytic differentiation, including decreased expression of c-Myc and increased expression of the cell cycle inhibitor p27kip1. These data suggest that malignant transformation by BCL-6 involves inhibition of differentiation and enhanced proliferation.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                14 August 2019
                2019
                : 10
                : 1909
                Affiliations
                [1] 1National Defense Medical Center, Graduate Institute of Life Sciences , Taipei, Taiwan
                [2] 2Genomics Research Center, Academia Sinica , Taipei, Taiwan
                [3] 3Graduate Institute of Immunology, College of Medicine, National Taiwan University , Taipei, Taiwan
                Author notes

                Edited by: Harry W. Schroeder, University of Alabama at Birmingham, United States

                Reviewed by: Paolo Casali, University of Texas Health Science Center San Antonio, United States; Lee Ann Garrett-Sinha, University at Buffalo, United States

                *Correspondence: Kuo-I Lin kuoilin@ 123456gate.sinica.edu.tw

                This article was submitted to B Cell Biology, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2019.01909
                6702260
                31474988
                0876465b-7938-45e6-bd4d-e2ec1ced6608
                Copyright © 2019 Wang, Tsai, Ko, Yang, Lin, Hung and Lin.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 29 March 2019
                : 29 July 2019
                Page count
                Figures: 7, Tables: 0, Equations: 0, References: 63, Pages: 16, Words: 10917
                Funding
                Funded by: Academia Sinica 10.13039/501100001869
                Award ID: AS-105-TP-B-08-01
                Award ID: AS-IA-107-L05
                Award ID: VTA107-T-1-2
                Funded by: Ministry of Science and Technology, Taiwan 10.13039/501100004663
                Categories
                Immunology
                Original Research

                Immunology
                regulatory b cells,b10 cells,blimp-1,il-10,candida albicans
                Immunology
                regulatory b cells, b10 cells, blimp-1, il-10, candida albicans

                Comments

                Comment on this article